SAB Biotherapeutics Inc. is an innovative biopharmaceutical company focused on the development of advanced immunotherapies targeting infectious diseases, autoimmune disorders, and cancer. Headquartered in Sioux Falls, South Dakota, with additional operations in Cambridge, Massachusetts, the company leverages its proprietary platform to produce fully human therapeutic antibodies from genetically engineered cows. This unique technology positions SAB Biotherapeutics at the forefront of addressing significant health challenges and delivering groundbreaking treatments in areas with considerable unmet medical needs, affirming its status as a key player in the biotherapeutics industry. Show more

Location: 777 W 41ST ST., MIAMI BEACH, FL, UNITED STATES, 33140, Miami Beach, FL, 33140, USA | Website: https://www.sabbiotherapeutics.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

209M

52 Wk Range

$1.00 - $4.68

Previous Close

$4.39

Open

$4.41

Volume

522,971

Day Range

$4.34 - $4.68

Enterprise Value

105.7M

Cash

29.42M

Avg Qtr Burn

-13.05M

Insider Ownership

12.36%

Institutional Own.

69.90%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.